Pharma & Healthcare
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2026
- Feb 24, 26
- ID: 708740
- Pages: 110
- Figures: 112
- Views: 1
This report delivers a comprehensive overview of the global Pneumococcal Polysaccharide Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pneumococcal Polysaccharide Vaccine. The Pneumococcal Polysaccharide Vaccine market size, estimates, and forecasts are provided in terms of sales volume (Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck & Co.
Pfizer
Sanofi Pasteur
Walvax
Sinovac
Sino Biopharm
Kangtai Bio
Zhifei Biological
AIM Bio
Antejin Biotechnology
Segment by Type
PCV13
PPSV23
Others
by Application
Hospital
Centers for Disease Control and Prevention
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pneumococcal Polysaccharide Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pneumococcal Polysaccharide Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck & Co.
Pfizer
Sanofi Pasteur
Walvax
Sinovac
Sino Biopharm
Kangtai Bio
Zhifei Biological
AIM Bio
Antejin Biotechnology
Segment by Type
PCV13
PPSV23
Others
by Application
Hospital
Centers for Disease Control and Prevention
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pneumococcal Polysaccharide Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pneumococcal Polysaccharide Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Definition
1.2 Pneumococcal Polysaccharide Vaccine by Type
1.2.1 Global Pneumococcal Polysaccharide Vaccine Market Value by Type: 2025 vs 2032
1.2.2 PCV13
1.2.3 PPSV23
1.2.4 Others
1.3 Pneumococcal Polysaccharide Vaccine by Application
1.3.1 Global Pneumococcal Polysaccharide Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Centers for Disease Control and Prevention
1.3.4 Others
1.4 Global Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2021–2032
1.4.2 Global Pneumococcal Polysaccharide Vaccine Sales 2021–2032
1.4.3 Global Pneumococcal Polysaccharide Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Date of Entry into the Industry
2.8 Global Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.8.1 Global Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.8.3 Global Pneumococcal Polysaccharide Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal Polysaccharide Vaccine Market Scenario by Region
3.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2021–2032
3.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2021–2026
3.2.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2027–2032
3.3 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021–2032
3.3.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021–2026
3.3.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2027–2032
3.4 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2021–2032)
3.4.3 North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021–2032)
3.5.3 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021–2032)
4.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021–2026)
4.1.2 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2027–2032)
4.1.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021–2032)
4.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021–2026)
4.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2027–2032)
4.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Pneumococcal Polysaccharide Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021–2032)
5.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021–2026)
5.1.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2027–2032)
5.1.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021–2032)
5.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021–2026)
5.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2027–2032)
5.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Pneumococcal Polysaccharide Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Company Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Company Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Walvax
6.4.1 Walvax Company Information
6.4.2 Walvax Description and Business Overview
6.4.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio
6.4.5 Walvax Recent Developments/Updates
6.5 Sinovac
6.5.1 Sinovac Company Information
6.5.2 Sinovac Description and Business Overview
6.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Sinovac Recent Developments/Updates
6.6 Sino Biopharm
6.6.1 Sino Biopharm Company Information
6.6.2 Sino Biopharm Description and Business Overview
6.6.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio
6.6.5 Sino Biopharm Recent Developments/Updates
6.7 Kangtai Bio
6.7.1 Kangtai Bio Company Information
6.7.2 Kangtai Bio Description and Business Overview
6.7.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
6.7.5 Kangtai Bio Recent Developments/Updates
6.8 Zhifei Biological
6.8.1 Zhifei Biological Company Information
6.8.2 Zhifei Biological Description and Business Overview
6.8.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio
6.8.5 Zhifei Biological Recent Developments/Updates
6.9 AIM Bio
6.9.1 AIM Bio Company Information
6.9.2 AIM Bio Description and Business Overview
6.9.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
6.9.5 AIM Bio Recent Developments/Updates
6.10 Antejin Biotechnology
6.10.1 Antejin Biotechnology Company Information
6.10.2 Antejin Biotechnology Description and Business Overview
6.10.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio
6.10.5 Antejin Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 Pneumococcal Polysaccharide Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Polysaccharide Vaccine Production Mode & Process Analysis
7.4 Pneumococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 Pneumococcal Polysaccharide Vaccine Sales Channels
7.4.2 Pneumococcal Polysaccharide Vaccine Distributors
7.5 Pneumococcal Polysaccharide Vaccine Customer Analysis
8 Pneumococcal Polysaccharide Vaccine Market Dynamics
8.1 Pneumococcal Polysaccharide Vaccine Industry Trends
8.2 Pneumococcal Polysaccharide Vaccine Market Drivers
8.3 Pneumococcal Polysaccharide Vaccine Market Challenges
8.4 Pneumococcal Polysaccharide Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pneumococcal Polysaccharide Vaccine by Type
1.2.1 Global Pneumococcal Polysaccharide Vaccine Market Value by Type: 2025 vs 2032
1.2.2 PCV13
1.2.3 PPSV23
1.2.4 Others
1.3 Pneumococcal Polysaccharide Vaccine by Application
1.3.1 Global Pneumococcal Polysaccharide Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Centers for Disease Control and Prevention
1.3.4 Others
1.4 Global Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2021–2032
1.4.2 Global Pneumococcal Polysaccharide Vaccine Sales 2021–2032
1.4.3 Global Pneumococcal Polysaccharide Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Date of Entry into the Industry
2.8 Global Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.8.1 Global Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.8.3 Global Pneumococcal Polysaccharide Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal Polysaccharide Vaccine Market Scenario by Region
3.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2021–2032
3.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2021–2026
3.2.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2027–2032
3.3 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021–2032
3.3.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021–2026
3.3.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2027–2032
3.4 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2021–2032)
3.4.3 North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021–2032)
3.5.3 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021–2032)
4.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021–2026)
4.1.2 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2027–2032)
4.1.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021–2032)
4.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021–2026)
4.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2027–2032)
4.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Pneumococcal Polysaccharide Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021–2032)
5.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021–2026)
5.1.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2027–2032)
5.1.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021–2032)
5.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021–2026)
5.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2027–2032)
5.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Pneumococcal Polysaccharide Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Company Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Company Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Walvax
6.4.1 Walvax Company Information
6.4.2 Walvax Description and Business Overview
6.4.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio
6.4.5 Walvax Recent Developments/Updates
6.5 Sinovac
6.5.1 Sinovac Company Information
6.5.2 Sinovac Description and Business Overview
6.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Sinovac Recent Developments/Updates
6.6 Sino Biopharm
6.6.1 Sino Biopharm Company Information
6.6.2 Sino Biopharm Description and Business Overview
6.6.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio
6.6.5 Sino Biopharm Recent Developments/Updates
6.7 Kangtai Bio
6.7.1 Kangtai Bio Company Information
6.7.2 Kangtai Bio Description and Business Overview
6.7.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
6.7.5 Kangtai Bio Recent Developments/Updates
6.8 Zhifei Biological
6.8.1 Zhifei Biological Company Information
6.8.2 Zhifei Biological Description and Business Overview
6.8.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio
6.8.5 Zhifei Biological Recent Developments/Updates
6.9 AIM Bio
6.9.1 AIM Bio Company Information
6.9.2 AIM Bio Description and Business Overview
6.9.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
6.9.5 AIM Bio Recent Developments/Updates
6.10 Antejin Biotechnology
6.10.1 Antejin Biotechnology Company Information
6.10.2 Antejin Biotechnology Description and Business Overview
6.10.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio
6.10.5 Antejin Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 Pneumococcal Polysaccharide Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Polysaccharide Vaccine Production Mode & Process Analysis
7.4 Pneumococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 Pneumococcal Polysaccharide Vaccine Sales Channels
7.4.2 Pneumococcal Polysaccharide Vaccine Distributors
7.5 Pneumococcal Polysaccharide Vaccine Customer Analysis
8 Pneumococcal Polysaccharide Vaccine Market Dynamics
8.1 Pneumococcal Polysaccharide Vaccine Industry Trends
8.2 Pneumococcal Polysaccharide Vaccine Market Drivers
8.3 Pneumococcal Polysaccharide Vaccine Market Challenges
8.4 Pneumococcal Polysaccharide Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pneumococcal Polysaccharide Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pneumococcal Polysaccharide Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) of Key Manufacturers (2021–2026)
Table 5. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal Polysaccharide Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pneumococcal Polysaccharide Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pneumococcal Polysaccharide Vaccine Sales by Region (Dose), 2021–2026
Table 18. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Pneumococcal Polysaccharide Vaccine Sales by Region (Dose), 2027–2032
Table 20. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2021–2026
Table 27. North America Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2027–2032
Table 28. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2021–2026
Table 32. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2027–2032
Table 33. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (Dose), 2021–2026
Table 37. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (Dose), 2027–2032
Table 38. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2021–2026
Table 42. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2027–2032
Table 43. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2021–2026
Table 47. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2027–2032
Table 48. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Type (2021–2026)
Table 51. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Type (2027–2032)
Table 52. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2021–2026)
Table 59. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2027–2032)
Table 60. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Application (2021–2026)
Table 61. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Application (2027–2032)
Table 62. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2021–2026)
Table 69. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2027–2032)
Table 70. Merck & Co. Company Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Merck & Co. Pneumococcal Polysaccharide Vaccine Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Pfizer Pneumococcal Polysaccharide Vaccine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Sanofi Pasteur Company Information
Table 81. Sanofi Pasteur Description and Business Overview
Table 82. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product
Table 84. Sanofi Pasteur Recent Developments/Updates
Table 85. Walvax Company Information
Table 86. Walvax Description and Business Overview
Table 87. Walvax Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Walvax Pneumococcal Polysaccharide Vaccine Product
Table 89. Walvax Recent Developments/Updates
Table 90. Sinovac Company Information
Table 91. Sinovac Description and Business Overview
Table 92. Sinovac Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Sinovac Pneumococcal Polysaccharide Vaccine Product
Table 94. Sinovac Recent Developments/Updates
Table 95. Sino Biopharm Company Information
Table 96. Sino Biopharm Description and Business Overview
Table 97. Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Sino Biopharm Pneumococcal Polysaccharide Vaccine Product
Table 99. Sino Biopharm Recent Developments/Updates
Table 100. Kangtai Bio Company Information
Table 101. Kangtai Bio Description and Business Overview
Table 102. Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Kangtai Bio Pneumococcal Polysaccharide Vaccine Product
Table 104. Kangtai Bio Recent Developments/Updates
Table 105. Zhifei Biological Company Information
Table 106. Zhifei Biological Description and Business Overview
Table 107. Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Zhifei Biological Pneumococcal Polysaccharide Vaccine Product
Table 109. Zhifei Biological Recent Developments/Updates
Table 110. AIM Bio Company Information
Table 111. AIM Bio Description and Business Overview
Table 112. AIM Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. AIM Bio Pneumococcal Polysaccharide Vaccine Product
Table 114. AIM Bio Recent Developments/Updates
Table 115. Antejin Biotechnology Company Information
Table 116. Antejin Biotechnology Description and Business Overview
Table 117. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product
Table 119. Antejin Biotechnology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Pneumococcal Polysaccharide Vaccine Distributors List
Table 123. Pneumococcal Polysaccharide Vaccine Customers List
Table 124. Pneumococcal Polysaccharide Vaccine Market Trends
Table 125. Pneumococcal Polysaccharide Vaccine Market Drivers
Table 126. Pneumococcal Polysaccharide Vaccine Market Challenges
Table 127. Pneumococcal Polysaccharide Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal Polysaccharide Vaccine
Figure 2. Global Pneumococcal Polysaccharide Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pneumococcal Polysaccharide Vaccine Market Share by Type: 2025 & 2032
Figure 4. PCV13 Product Picture
Figure 5. PPSV23 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pneumococcal Polysaccharide Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Pneumococcal Polysaccharide Vaccine Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Centers for Disease Control and Prevention
Figure 11. Others
Figure 12. Global Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Pneumococcal Polysaccharide Vaccine Market Size (US$ Million), 2021–2032
Figure 14. Global Pneumococcal Polysaccharide Vaccine Sales (Dose), 2021–2032
Figure 15. Global Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose), 2021–2032
Figure 16. Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 17. Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2025
Figure 18. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in Pneumococcal Polysaccharide Vaccine in 2025
Figure 20. Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021–2032)
Figure 23. North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021–2032)
Figure 24. United States Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021–2032)
Figure 27. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021–2032)
Figure 28. Germany Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021–2032)
Figure 35. China Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021–2032)
Figure 43. Latin America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Type (2021–2032)
Figure 55. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2021–2032)
Figure 56. Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Application (2021–2032)
Figure 58. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2021–2032)
Figure 59. Pneumococcal Polysaccharide Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Pneumococcal Polysaccharide Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pneumococcal Polysaccharide Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) of Key Manufacturers (2021–2026)
Table 5. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal Polysaccharide Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pneumococcal Polysaccharide Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pneumococcal Polysaccharide Vaccine Sales by Region (Dose), 2021–2026
Table 18. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Pneumococcal Polysaccharide Vaccine Sales by Region (Dose), 2027–2032
Table 20. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2021–2026
Table 27. North America Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2027–2032
Table 28. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2021–2026
Table 32. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2027–2032
Table 33. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (Dose), 2021–2026
Table 37. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (Dose), 2027–2032
Table 38. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2021–2026
Table 42. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2027–2032
Table 43. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2021–2026
Table 47. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (Dose), 2027–2032
Table 48. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Type (2021–2026)
Table 51. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Type (2027–2032)
Table 52. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2021–2026)
Table 59. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2027–2032)
Table 60. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Application (2021–2026)
Table 61. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Application (2027–2032)
Table 62. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2021–2026)
Table 69. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2027–2032)
Table 70. Merck & Co. Company Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Merck & Co. Pneumococcal Polysaccharide Vaccine Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Pfizer Pneumococcal Polysaccharide Vaccine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Sanofi Pasteur Company Information
Table 81. Sanofi Pasteur Description and Business Overview
Table 82. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product
Table 84. Sanofi Pasteur Recent Developments/Updates
Table 85. Walvax Company Information
Table 86. Walvax Description and Business Overview
Table 87. Walvax Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Walvax Pneumococcal Polysaccharide Vaccine Product
Table 89. Walvax Recent Developments/Updates
Table 90. Sinovac Company Information
Table 91. Sinovac Description and Business Overview
Table 92. Sinovac Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Sinovac Pneumococcal Polysaccharide Vaccine Product
Table 94. Sinovac Recent Developments/Updates
Table 95. Sino Biopharm Company Information
Table 96. Sino Biopharm Description and Business Overview
Table 97. Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Sino Biopharm Pneumococcal Polysaccharide Vaccine Product
Table 99. Sino Biopharm Recent Developments/Updates
Table 100. Kangtai Bio Company Information
Table 101. Kangtai Bio Description and Business Overview
Table 102. Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Kangtai Bio Pneumococcal Polysaccharide Vaccine Product
Table 104. Kangtai Bio Recent Developments/Updates
Table 105. Zhifei Biological Company Information
Table 106. Zhifei Biological Description and Business Overview
Table 107. Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Zhifei Biological Pneumococcal Polysaccharide Vaccine Product
Table 109. Zhifei Biological Recent Developments/Updates
Table 110. AIM Bio Company Information
Table 111. AIM Bio Description and Business Overview
Table 112. AIM Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. AIM Bio Pneumococcal Polysaccharide Vaccine Product
Table 114. AIM Bio Recent Developments/Updates
Table 115. Antejin Biotechnology Company Information
Table 116. Antejin Biotechnology Description and Business Overview
Table 117. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product
Table 119. Antejin Biotechnology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Pneumococcal Polysaccharide Vaccine Distributors List
Table 123. Pneumococcal Polysaccharide Vaccine Customers List
Table 124. Pneumococcal Polysaccharide Vaccine Market Trends
Table 125. Pneumococcal Polysaccharide Vaccine Market Drivers
Table 126. Pneumococcal Polysaccharide Vaccine Market Challenges
Table 127. Pneumococcal Polysaccharide Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal Polysaccharide Vaccine
Figure 2. Global Pneumococcal Polysaccharide Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pneumococcal Polysaccharide Vaccine Market Share by Type: 2025 & 2032
Figure 4. PCV13 Product Picture
Figure 5. PPSV23 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pneumococcal Polysaccharide Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Pneumococcal Polysaccharide Vaccine Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Centers for Disease Control and Prevention
Figure 11. Others
Figure 12. Global Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Pneumococcal Polysaccharide Vaccine Market Size (US$ Million), 2021–2032
Figure 14. Global Pneumococcal Polysaccharide Vaccine Sales (Dose), 2021–2032
Figure 15. Global Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose), 2021–2032
Figure 16. Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 17. Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2025
Figure 18. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in Pneumococcal Polysaccharide Vaccine in 2025
Figure 20. Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021–2032)
Figure 23. North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021–2032)
Figure 24. United States Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021–2032)
Figure 27. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021–2032)
Figure 28. Germany Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021–2032)
Figure 35. China Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021–2032)
Figure 43. Latin America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Type (2021–2032)
Figure 55. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2021–2032)
Figure 56. Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Application (2021–2032)
Figure 58. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2021–2032)
Figure 59. Pneumococcal Polysaccharide Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Extruded Grade PETG Market Research Report 2026
Feb 24, 26
Global Particle Testing & Analysis Market Research Report 2026
Feb 24, 26
Global Plastic Lens for Automotive Lights Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232